A Medication Plan for Safer Medication Treatment in Older Persons

NCT06016140 | Completed

• 1 other identifier: 2022-04430-01
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Harm from medications is still a concern in an aged population. As medication treatment for older persons many times are complex, a feasibility study can be helpful to support decisions about future evaluation and implementation of an intervention. In this study, the overall aim is to assess feasibility, acceptability and potential effects of usage of a co-designed medication plan for older persons with medication treatment. The study will take place in the primary care setting in Sweden, and involve persons 75 years or older using five or more medications on daily basis, physicians at primary care centers and persons supporting the older person in their medication use a home. During an appointment, the physician and older person will agree on a medication plan, that will be documented in the older person's electronic health record and printed out on paper. After three month, the potential outcomes of a medication plan will be collected, together with data about feasibility and acceptability of the intervention. Two questionnaires will be used, addressing usability and patient safety. Moreover, remote interviews with participants will be performed to address usability and patient safety. Information about the medication plan will be collected from the electronic health record. Data analysis will be done with descriptive statistics and qualitative content analysis. Expected outcomes are an assessment of feasibility and acceptability, and potential outcomes, to support decision on a future evaluation of the medication plan.

Conditions

Patient Safety

Keywords

aged; medication; feasibility study; primary care

Outcome Measures

Primary Outcomes (1)

• Feasibility of the intervention

  For feasibility of the intervention, the secondary outcome measures will be analyzed together to address the feasibility of chosen study methods and of the intervention of using a co-designed medication plan

  Three months

Secondary Outcomes (6)

• Usability of the medication plan

  Three months

• Usability of the medication plan

  Three months

• Patient safety

  Three months

• Patient safety

  Three months

• Acceptability of the intervention

  Three months

Study Arms (1)

Intervention group

EXPERIMENTAL

Medication Plan Prototype

Other: Medication plan

Interventions

Medication plan OTHER

Involved participants will jointly agreed on continued medication treatment (treatment aim, planned monitring and evaluation and responsibility, and the physician will document the plan in the electronic health record

Intervention group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Physicians and nurses: regular contact with the older person regarding medications, employment at a primary care center and ability to understand and communicate in Swedish
• Older persons: age \>75 years old, five or more medications on a regular basis and ability to understand and communicate in Swedish
• Next-of-kin: age \> 18 years old, regular contact with the older person regarding medications, ability to understand and communicate in Swedish

You may not qualify if:

• Older persons: impaired cognitive ability affecting the ability to provide informed consent (Diagnosis code for dementia) and late palliative phase, here defined as estimated life expectancy shorter than six months
• Next-of-kin: impaired cognitive ability affecting the ability to provide informed consent

Sponsors & Collaborators

• Region Jönköping County: lead
• Jonkoping University: collaborator

Study Sites (1)

Region Jonkoping County

Jönköping, 55185, Sweden

Location

Related Publications (1)

• Holmqvist M, Ros A, Thor J, Johansson L. Applying a co-designed medication plan for safer medication treatment in older persons: a feasibility study. Pilot Feasibility Stud. 2025 Jul 3;11(1):92. doi: 10.1186/s40814-025-01661-1.

  PMID: 40611301 DERIVED

Study Officials

• Malin Holmqvist

  Region Jönköping County

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD student, pharmacist

Study Record Dates

• First Submitted: June 20, 2023
• First Posted: August 29, 2023
• Study Start: June 1, 2022
• Primary Completion: September 1, 2023
• Study Completion: November 1, 2023
• Last Updated: January 9, 2024

Record last verified: 2024-01

Data Sharing

• IPD Sharing: Will not share

Locations

SE (1)